Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender Women
Clinical trial NCT03060785 · COMPLETED
Trial details
- NCT number
- NCT03060785
- Sponsor
- Johns Hopkins University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-08
- Primary completion
- 2018-05-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.